Option Care Health Beheer
Beheer criteriumcontroles 2/4
De CEO Option Care Health is John Rademacher, benoemd in Aug2017, heeft een ambtstermijn van 7.25 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 16.61M, bestaande uit 6% salaris en 94% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.11% van de aandelen van het bedrijf, ter waarde $ 4.48M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 2.6 jaar en 5.8 jaar.
Belangrijke informatie
John Rademacher
Algemeen directeur
US$16.6m
Totale compensatie
| Percentage CEO-salaris | 6.0% |
| Dienstverband CEO | 7.3yrs |
| Eigendom CEO | 0.1% |
| Management gemiddelde ambtstermijn | 2.6yrs |
| Gemiddelde ambtstermijn bestuur | 5.8yrs |
Recente managementupdates
Recent updates
Results: Option Care Health, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates
Nov 02
Should You Think About Buying Option Care Health, Inc. (NASDAQ:OPCH) Now?
Oct 17There's Reason For Concern Over Option Care Health, Inc.'s (NASDAQ:OPCH) Price
Aug 30Option Care Health: Revenue Lines Not Pulling Economic Weight (Rating Downgrade)
Aug 16We Think Option Care Health (NASDAQ:OPCH) Can Stay On Top Of Its Debt
Aug 15What Does Option Care Health, Inc.'s (NASDAQ:OPCH) Share Price Indicate?
Jul 15Option Care Health: A Deep Dive Into Its Market Dominance
May 31Option Care Health, Inc.'s (NASDAQ:OPCH) Shareholders Might Be Looking For Exit
May 23We Ran A Stock Scan For Earnings Growth And Option Care Health (NASDAQ:OPCH) Passed With Ease
May 10Does Option Care Health (NASDAQ:OPCH) Have A Healthy Balance Sheet?
Apr 11Is Option Care Health, Inc. (NASDAQ:OPCH) Trading At A 42% Discount?
Mar 28Is It Time To Consider Buying Option Care Health, Inc. (NASDAQ:OPCH)?
Feb 12Option Care Health (NASDAQ:OPCH) Has A Pretty Healthy Balance Sheet
Jan 02There's Reason For Concern Over Option Care Health, Inc.'s (NASDAQ:OPCH) Price
Dec 19Is There An Opportunity With Option Care Health, Inc.'s (NASDAQ:OPCH) 27% Undervaluation?
Dec 06With EPS Growth And More, Option Care Health (NASDAQ:OPCH) Makes An Interesting Case
Nov 08Is It Too Late To Consider Buying Option Care Health, Inc. (NASDAQ:OPCH)?
Oct 26Does Option Care Health (NASDAQ:OPCH) Have A Healthy Balance Sheet?
Sep 13Is Option Care Health, Inc. (NASDAQ:OPCH) Trading At A 24% Discount?
Aug 30Does Option Care Health (NASDAQ:OPCH) Deserve A Spot On Your Watchlist?
Aug 10Is Option Care Health, Inc. (NASDAQ:OPCH) Potentially Undervalued?
Jul 27Here's Why Option Care Health (NASDAQ:OPCH) Can Manage Its Debt Responsibly
Jun 09An Intrinsic Calculation For Option Care Health, Inc. (NASDAQ:OPCH) Suggests It's 37% Undervalued
May 25What Is Option Care Health, Inc.'s (NASDAQ:OPCH) Share Price Doing?
Apr 24Here's Why We Think Option Care Health (NASDAQ:OPCH) Might Deserve Your Attention Today
Apr 11We Like These Underlying Return On Capital Trends At Option Care Health (NASDAQ:OPCH)
Mar 17Option Care Health (NASDAQ:OPCH) Seems To Use Debt Quite Sensibly
Mar 05Estimating The Intrinsic Value Of Option Care Health, Inc. (NASDAQ:OPCH)
Feb 21Should You Think About Buying Option Care Health, Inc. (NASDAQ:OPCH) Now?
Jan 16Should You Be Adding Option Care Health (NASDAQ:OPCH) To Your Watchlist Today?
Jan 04Some Shareholders Feeling Restless Over Option Care Health, Inc.'s (NASDAQ:OPCH) P/E Ratio
Dec 05We Think Option Care Health (NASDAQ:OPCH) Can Stay On Top Of Its Debt
Nov 22The Return Trends At Option Care Health (NASDAQ:OPCH) Look Promising
Nov 10Option Care Health, Inc.'s (NASDAQ:OPCH) Intrinsic Value Is Potentially 41% Above Its Share Price
Sep 30Is Now The Time To Put Option Care Health (NASDAQ:OPCH) On Your Watchlist?
Sep 12Option Care Health announces secondary offering of 11M shares of common stock
Aug 16Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$209m |
| Jun 30 2024 | n/a | n/a | US$211m |
| Mar 31 2024 | n/a | n/a | US$273m |
| Dec 31 2023 | US$17m | US$1m | US$267m |
| Sep 30 2023 | n/a | n/a | US$257m |
| Jun 30 2023 | n/a | n/a | US$240m |
| Mar 31 2023 | n/a | n/a | US$159m |
| Dec 31 2022 | US$7m | US$954k | US$151m |
| Sep 30 2022 | n/a | n/a | US$178m |
| Jun 30 2022 | n/a | n/a | US$175m |
| Mar 31 2022 | n/a | n/a | US$173m |
| Dec 31 2021 | US$8m | US$669k | US$140m |
| Sep 30 2021 | n/a | n/a | US$82m |
| Jun 30 2021 | n/a | n/a | US$48m |
| Mar 31 2021 | n/a | n/a | US$9m |
| Dec 31 2020 | US$1m | US$500k | -US$8m |
| Sep 30 2020 | n/a | n/a | -US$42m |
| Jun 30 2020 | n/a | n/a | -US$86m |
| Mar 31 2020 | n/a | n/a | -US$92m |
| Dec 31 2019 | US$856k | US$487k | -US$76m |
Compensatie versus markt: De totale vergoeding ($USD 16.61M ) John } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 6.65M ).
Compensatie versus inkomsten: De beloning van John is het afgelopen jaar met meer dan 20% gestegen, terwijl de winst van het bedrijf met meer dan 20% is gedaald.
CEO
John Rademacher (57 yo)
7.3yrs
Tenure
US$16,613,200
Compensatie
Mr. John C. Rademacher is the President of Option Care Health, Inc. (formerly known as Option Care Enterprises Inc.) and has serves as a Director since 2019. Mr. Rademacher is the Chief Executive Officer o...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| CEO, President & Director | 7.3yrs | US$16.61m | 0.11% $ 4.5m | |
| Executive VP & CFO | 9.3yrs | US$8.32m | 0.040% $ 1.6m | |
| Chief Operating Officer | 1.8yrs | US$3.52m | 0.028% $ 1.1m | |
| General Counsel & Corporate Secretary | 2.6yrs | US$2.55m | 0.010% $ 429.2k | |
| Chief Human Resources & Chief Diversity Officer | 2.8yrs | US$2.08m | 0.025% $ 1.0m | |
| Principal Accounting Officer | less than a year | geen gegevens | 0.0041% $ 169.5k | |
| Chief Information Officer | no data | geen gegevens | geen gegevens | |
| Senior VP & Chief Compliance Officer | 2.8yrs | geen gegevens | geen gegevens | |
| Senior Vice President of Operations | no data | geen gegevens | geen gegevens | |
| Chief Growth Officer | 2.4yrs | geen gegevens | 0.0050% $ 204.7k | |
| Chief Medical Officer | no data | geen gegevens | geen gegevens | |
| Senior VP & Chief Information Security Officer | less than a year | geen gegevens | geen gegevens |
2.6yrs
Gemiddelde duur
45.5yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van OPCH wordt beschouwd als ervaren (gemiddelde ambtstermijn 2.6 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| CEO, President & Director | 5.8yrs | US$16.61m | 0.11% $ 4.5m | |
| Independent Director | 5.8yrs | US$245.00k | 0.012% $ 501.8k | |
| Director | less than a year | geen gegevens | geen gegevens | |
| Independent Non Executive Chairman of the Board | 5.8yrs | US$571.55k | 0.17% $ 6.8m | |
| Independent Director | 9.8yrs | US$237.50k | 0.063% $ 2.6m | |
| Independent Director | 5.8yrs | US$255.00k | 0.014% $ 583.0k | |
| Independent Director | 9.8yrs | US$257.00k | 0.021% $ 871.1k | |
| Independent Director | 2.5yrs | US$248.50k | 0.0028% $ 114.1k | |
| Independent Director | less than a year | geen gegevens | 0.0042% $ 170.3k | |
| Independent Director | less than a year | geen gegevens | 0.0010% $ 41.9k | |
| Independent Director | 2.5yrs | US$250.00k | 0.0010% $ 41.9k |
5.8yrs
Gemiddelde duur
62yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van OPCH wordt beschouwd als ervaren (gemiddelde ambtstermijn 5.8 jaar).